Middle cerebral artery occlusion in the rabbit using selective ...
We describe a technique for MCA thrombo-occlusion in the rabbit with real-time ... Plasmin (Talecris Biotherapeutics, Research Triangle Park, NC) (1) was ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...
|
Heparin-Induced Thrombocytopenia: Treatment Options and Considerations
Management of heparin-induced thrombo-cytopenia: a critical comparison of lepirudin and ..... Research Triangle Park, NC: GlaxoSmithKline; July 7, 2005.
...
http://www.medscape.com/viewarticle/555434_6...
|
BioMed Central | Full text | Update on Abciximab Readministration ...
In the Duke Interventional Catheterization Laboratory, Durham, NC, the abciximab .... Curtis BR, McFarland JG, Garrity MM: Thrombo-cyto-penia induced by ...
http://www.biomedcentral.com/1523-3839/id/cr-ic2321/abstract...
|
21 selected items - PubMed Results
Duke Clinical Research Institute, 2400 Pratt St, Room 7035, Durham, NC ..... Consequences of thrombo-embolism, such as slow flow' or no-reflow' are in ...
http://www.ncbi.nlm.nih.gov/pubmed/18258817,18174449,1809683...
|
1998 Guidelines for Treatment of Sexually Transmitted Diseases
Health International, Research Triangle Park, NC; Anne M. Rompalo, M.D., ...... syndrome resembling either hemolytic uremic syndrome or thrombotic thrombo- ...
http://www.cdc.gov/nchstp/dstd/1998_STD_Guidelines/98m1633.p...
|
Use of activated recombinant factor VII for severe coagulopathy ...
Patient demographics, rFVIIa dose, mortality and thrombo-embolic ..... with hyoperfusion and target organ injury) that would predispose them to develop ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...
|
Vital Health and Statistics, Series 11, No. 243 (12/98)
thrombo-occlusive heart disease. Vitamin B. 12. is commonly referred to as ...... Research Triangle Park, NC: Research. Triangle Institute, 1996. ...
http://www.cdc.gov/nchs/data/series/sr_11/sr11_243.pdf...
|
Journal of Cerebral Blood Flow & Metabolism - Establishing a ...
The ischemic penumbra is, therefore, the main target for therapeutic ..... wash- out of thrombo-embolic material (Gu et al, 2001, 1999b; Hilger et al, 2004). ...
http://www.nature.com/jcbfm/journal/v26/n7/full/9600245a.htm...
|
Hormone Replacement Therapy and Risk of Venous Thromboembolism ...
The analytic frameworks in Figures 1 and 2 show the target populations, interventions, ...... thrombo$.tw. 22. thrombolytic therapy. 23. exp hemorrhage
...
http://www.ahrq.gov/downloads/pub/prevent/pdfser/hrtriskser....
|
J CASE DEPARTMENT OF PATHOLOGY
and vascular lesions as a central target for the development of Alz- .... Fetal thrombo-occlusive lesions: Nosology and reproduci- ...
http://www.case.edu/med/pathology/newsletter/NovDec2003Newsl...
|
